Aclarion Inc. (Nasdaq: ACON, ACONW) has published a peer-reviewed article in Clinicoeconomics and Outcomes Research, titled “The Comparison of Cost-Effectiveness Between Magnetic Resonance Spectroscopy and Provocative Discography in the Identification of Chronic Low Back Pain Surgery Candidates.” The independent cost-effectiveness analysis concludes that Nociscan is effective and less costly compared to provocative discography. The findings…